{"datasetJSONCreationDateTime":"2024-11-11T15:09:19","datasetJSONVersion":"1.1.0","fileOID":"www.cdisc.org/StudyMSGv2/1/Define-XML_2.1.0/2024-11-11/ts","dbLastModifiedDateTime":"2020-08-21T09:14:24","originator":"CDISC SDTM MSG Team","sourceSystem":{"name":"SAS on X64_10PRO","version":"9.0401M7"},"studyOID":"cdisc.com/CDISCPILOT01","metaDataVersionOID":"MDV.MSGv2.0.SDTMIG.3.3.SDTM.1.7","metaDataRef":"define.xml","itemGroupOID":"IG.TS","records":51,"name":"TS","label":"Trial Summary","columns":[{"itemOID":"IT.TS.STUDYID","name":"STUDYID","label":"Study Identifier","dataType":"string","length":12,"keySequence":1},{"itemOID":"IT.TS.DOMAIN","name":"DOMAIN","label":"Domain Abbreviation","dataType":"string","length":2},{"itemOID":"IT.TS.TSSEQ","name":"TSSEQ","label":"Sequence Number","dataType":"integer","keySequence":4},{"itemOID":"IT.TS.TSGRPID","name":"TSGRPID","label":"Group ID","dataType":"string","length":200},{"itemOID":"IT.TS.TSPARMCD","name":"TSPARMCD","label":"Trial Summary Parameter Short Name","dataType":"string","length":8,"keySequence":2},{"itemOID":"IT.TS.TSPARM","name":"TSPARM","label":"Trial Summary Parameter","dataType":"string","length":40},{"itemOID":"IT.TS.TSVAL","name":"TSVAL","label":"Parameter Value","dataType":"string","length":200,"keySequence":3},{"itemOID":"IT.TS.TSVALNF","name":"TSVALNF","label":"Parameter Null Flavor","dataType":"string","length":4},{"itemOID":"IT.TS.TSVALCD","name":"TSVALCD","label":"Parameter Value Code","dataType":"string","length":200},{"itemOID":"IT.TS.TSVCDREF","name":"TSVCDREF","label":"Name of the Reference Terminology","dataType":"string","length":200},{"itemOID":"IT.TS.TSVCDVER","name":"TSVCDVER","label":"Version of the Reference Terminology","dataType":"string","length":200}],"rows":[["CDISCPILOT01","TS",1,"","ACTSUB","Actual Number of Subjects","18","","","",""],["CDISCPILOT01","TS",1,"","ADAPT","Adaptive Design","N","","C49487","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","ADDON","Added on to Existing Treatments","N","","C49487","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","AGEMAX","Planned Maximum Age of Subjects","","PINF","","",""],["CDISCPILOT01","TS",1,"","AGEMIN","Planned Minimum Age of Subjects","P50Y","","","ISO 8601",""],["CDISCPILOT01","TS",1,"CUTOFF","DCUTDESC","Data Cutoff Description","DATABASE LOCK","","","",""],["CDISCPILOT01","TS",1,"CUTOFF","DCUTDTC","Data Cutoff Date","2015-03-31","","","ISO 8601",""],["CDISCPILOT01","TS",1,"PLACEBO","DOSE","Dose per Administration","0","","","",""],["CDISCPILOT01","TS",2,"LOW-DOSE","DOSE","Dose per Administration","54","","","",""],["CDISCPILOT01","TS",3,"HIGH-DOSE","DOSE","Dose per Administration","54","","","",""],["CDISCPILOT01","TS",4,"HIGH-DOSE","DOSE","Dose per Administration","81","","","",""],["CDISCPILOT01","TS",1,"","DOSFRM","Dose Form","INJECTION","","C42946","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","DOSFRQ","Dosing Frequency","QD","","C25473","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","DOSU","Dose Units","mg","","C28253","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","FCNTRY","Planned Country of Investigational Sites","USA","","USA","ISO 3166-1 alpha-3",""],["CDISCPILOT01","TS",1,"","HLTSUBJI","Healthy Subject Indicator","N","","C49487","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","INDIC","Trial Disease/Condition Indication","Alzheimer's Disease (Disorder)","","26929004","SNOMED","2019-03-01"],["CDISCPILOT01","TS",1,"","INTMODEL","Intervention Model","PARALLEL","","C82639","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","INTTYPE","Intervention Type","DRUG","","C1909","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","LENGTH","Trial Length","P28W","","","ISO 8601",""],["CDISCPILOT01","TS",1,"","NARMS","Planned Number of Arms","3","","","",""],["CDISCPILOT01","TS",1,"EFFICACY","OBJPRIM","Trial Primary Objective","To document the efficacy profile of Zanomaline.","","","",""],["CDISCPILOT01","TS",2,"SAFETY","OBJPRIM","Trial Primary Objective","To document the safety profile of Zanomaline.","","","",""],["CDISCPILOT01","TS",1,"EFFICACY","OUTMSPRI","Primary Outcome Measure","To assess the dose-dependent improvement in subject depression. Improved scores on the Patient Health Questionnaire(PHQ-9) and the Hamilton Depression Rating Scale(HAMD 17) will indicate improvements.","","","",""],["CDISCPILOT01","TS",2,"EFFICACY","OUTMSPRI","Primary Outcome Measure","To assess the dose-dependent improvements in satisfaction with subjects' lives as a whole. Improved scores on the Satisfaction With Life Survery (SWLS) will indicate improvements.","","","",""],["CDISCPILOT01","TS",3,"EFFICACY","OUTMSPRI","Primary Outcome Measure","To assess the dose-dependent improvements in subject memory and learning. Improved scores on the Auditory Verbal Learning Test (AVLT-REY) will indicate improvements.","","","",""],["CDISCPILOT01","TS",4,"SAFETY","OUTMSPRI","Primary Outcome Measure","Type, frequency, and severity of laboratory abnormalities","","","",""],["CDISCPILOT01","TS",5,"SAFETY","OUTMSPRI","Primary Outcome Measure","Type, frequency, and severity of adverse events (AEs)","","","",""],["CDISCPILOT01","TS",1,"","PCLAS","Pharmacologic Class","Acetylcholine Release Inhibitor","","N0000175771","MED-RT",""],["CDISCPILOT01","TS",1,"","PLANSUB","Planned Number of Subjects","20","","","",""],["CDISCPILOT01","TS",1,"","RANDOM","Trial is Randomized","Y","","C49488","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","RANDQT","Randomization Quotient","0.67","","","",""],["CDISCPILOT01","TS",1,"","REGID","Registry Identifier","NCT00000000","","NCT00000000","clinicaltrials.gov",""],["CDISCPILOT01","TS",1,"","ROUTE","Route of Administration","SUBCUTANEOUS","","C38299","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","SDTIGVER","SDTM IG Version","3.3","","","",""],["CDISCPILOT01","TS",1,"","SDTMVER","SDTM Version","1.7","","","",""],["CDISCPILOT01","TS",1,"","SENDTC","Study End Date","2014-11-01","","","ISO 8601",""],["CDISCPILOT01","TS",1,"","SEXPOP","Sex of Participants","BOTH","","C49636","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","SPONSOR","Clinical Study Sponsor","SDTM Metadata Submission Guidelines Team","","","",""],["CDISCPILOT01","TS",1,"","SSTDTC","Study Start Date","2012-10-06","","","ISO 8601",""],["CDISCPILOT01","TS",1,"","STOPRULE","Study Stop Rules","NONE","","","",""],["CDISCPILOT01","TS",1,"","STYPE","Study Type","INTERVENTIONAL","","C98388","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","TBLIND","Trial Blinding Schema","DOUBLE BLIND","","C15228","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","TCNTRL","Control Type","PLACEBO","","C49648","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","TDIGRP","Diagnosis Group","Patients with Probable Mild to Moderate Alzheimers Disease","","","",""],["CDISCPILOT01","TS",1,"","TINDTP","Trial Intent Type","TREATMENT","","C49656","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","TITLE","Trial Title","Safety and Efficacy of Zanomaline in Patients with Mild to Moderate Alzheimers Disease.","","","",""],["CDISCPILOT01","TS",1,"","TPHASE","Trial Phase Classification","PHASE II TRIAL","","C15601","CDISC","2020-03-27"],["CDISCPILOT01","TS",1,"","TRT","Investigational Therapy or Treatment","Zanomaline","","0XXX0X00XX","UNII",""],["CDISCPILOT01","TS",1,"","TTYPE","Trial Type","SAFETY","","C49667","CDISC","2020-03-27"],["CDISCPILOT01","TS",2,"","TTYPE","Trial Type","EFFICACY","","C49666","CDISC","2020-03-27"]]}